Form 8-K - Current report:
SEC Accession No. 0001628908-23-000056
Filing Date
2023-04-19
Accepted
2023-04-19 16:12:34
Documents
14
Period of Report
2023-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 04.19.2023 8-K evh-20230419.htm   iXBRL 8-K 42281
2 EX-99.1 a2023419exhibit991.htm EX-99.1 11255
6 imagea.jpg GRAPHIC 27806
  Complete submission text file 0001628908-23-000056.txt   238367

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20230419.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20230419_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20230419_pre.xml EX-101.PRE 13055
8 EXTRACTED XBRL INSTANCE DOCUMENT evh-20230419_htm.xml XML 11865
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

IRS No.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 23830167
SIC: 8741 Services-Management Services